Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration

Circulation

Volumn 107, Issue 19, 2003, Pages 2475-2479

  Jacob, Giris ^a   Costa, Fernando ^b   Vincent, Simi ^c   Robertson, David ^c   Biaggioni, Italo ^c,d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b AMERICAN HEART ASSOCIATION   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Blood flow; Catecholamines; Nervous system, sympathetic; Norepinephrine

Indexed keywords

CATECHOLAMINE; NORADRENALIN; PHENYLEPHRINE; TYRAMINE;

ADRENERGIC STIMULATION; ADRENERGIC TRANSMISSION; ADULT; ARTICLE; CARDIOVASCULAR EFFECT; COLD PRESSOR TEST; CONTROLLED STUDY; DRUG INFUSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; MALE; NEUROTRANSMITTER RELEASE; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; SYMPATHETIC NERVE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

NON-PROGRAMMATIC;

ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; COLD; DOPAMINE; FOREARM; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; NOREPINEPHRINE; PHENYLEPHRINE; PHYSICAL STIMULATION; REFERENCE VALUES; REGIONAL BLOOD FLOW; TYRAMINE; VASOCONSTRICTOR AGENTS; VASODILATION; VEINS;

EID: 0037842002     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000065605.37863.C0     Document Type: Article

References (27)

1. Brown C, Taniguchi G, Yip K. The monoamine oxidase inhibitortyramine interaction. J Clin Pharmacol. 1989;29:529-532.
2. Goldstein DS, Nurnberger J Jr, Simmons S, et al. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. Life Sci. 1983;32:1057-1063.
3. Meredith IT, Esler MD, Cox HS, et al. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res. 1991;1:187-194.
4. Morgan-Hughes NJ, Kenny RA, Scott CD, et al. Vasodepressor reactions after orthotopic cardiac transplantation: relationship to reinnervation status. Clin Auton Res. 1994;4:125-129.
5. Burke MN, McGinn AL, Homans DC, et al. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation. 1995;91: 72-78.
6. Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343:1008-1014.
7. Lameris TW, de Zeeuw S, Duncker DJ, et al. Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release. Circulation. 2002;106:860-865.
8. Vincent S, Robertson D. The broader view: catecholamine abnormalities. Clin Auton Res. 2002;12(suppl 1):I44-I49.
9. Chang PC, Kriek E, van der Krogt JA, et al. Does regional norepinephrine spillover represent local sympathetic activity? Hypertension. 1991;18: 56-66.
10. Eisenach JH, Clark ES, Charkoudian N, et al. Effects of chronic sympathectomy on vascular function in the human forearm. J Appl Physiol. 2002;92:2019-2025.
11. Jacob G, Shannon JR, Costa F, et al. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation. 1999;99:1706-1712.
12. Bianchetti MG, Minder I, Beretta-Piccoli C, et al. Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr. 1982;60:465-470.
13. Poller U, Schafers RF, Schmuck S, et al. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers. Naunyn Schmiedebergs Arch Pharmacol. 1997;356:100-106.
14. Schafers RF, Poller U, Ponicke K, et al. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:239-249.
15. Jie K, van Brummelen P, Vermey P, et al. Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol. 1987;9:407-413.
16. Victor RG, Leimbach WN Jr, Seals DR, et al. Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension. 1987;9:429-436.
17. Costa F, Biaggioni I. Role of nitric oxide in adenosine-induced vasodilation in humans. Hypertension. 1998;31:1061-1064.
18. Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985.
19. Goldstein DS, Eisenhofer G, Stull R, et al. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest. 1988;81:213-220.
20. Jacob G, Costa F, Shannon J, et al. Dissociation between neural and vascular responses to sympathetic stimulation: contribution of local adrenergic receptor function. Hypertension. 2000;35:76-81.
21. Jie K, van Brummelen P, Vermey P, et al. Differences between exogenous and endogenous noradrenaline in the effects on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. J Hypertens Suppl. 1985;3(suppl 3):S145-S147.
22. Chow LT, Chow SS, Anderson RH, et al. Autonomic innervation of the human cardiac conduction system: changes from infancy to senility: an immunohistochemical and histochemical analysis. Anat Rec. 2001;264: 169-182.
23. Forman MB, Robertson D. Goldberg M, et al. Effect of tyramine on myocardial catecholamine release in coronary heart disease. Am J Cardiol. 1984;53:476-480.
24. Tschakovsky ME, Sujirattanawimol K, Ruble SB, et al. Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol. 2002;541:623-635.
25. Graefe KH, Bossle F, Wolfel R, et al. Sympathomimetic effects of MIBG: comparison with tyramine. J Nucl Med. 1999;40:1342-1351.
26. 18F]fluorodopamine in humans. Clin Exp Hypertens. 1997;19: 155-161.
27. Hiroi T, Imaoka S, Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun. 1998;249:838-843.